Loading…
MEDIROM Healthcare Technologies Inc. is projected to decline to $0.9353 by 2027, a -6% move from its current price of $0.99. MRM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.9553 | $0.9896 | $1.03 | -0.04% |
| Jul 13 | $0.941 | $0.9892 | $1.04 | -0.09% |
| Jul 14 | $0.9301 | $0.9887 | $1.05 | -0.13% |
| Jul 15 | $0.921 | $0.9883 | $1.06 | -0.17% |
| Jul 16 | $0.9129 | $0.9879 | $1.07 | -0.21% |
| Jul 17 | $0.9057 | $0.9875 | $1.08 | -0.26% |
| Jul 18 | $0.8991 | $0.987 | $1.08 | -0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8991 | $0.987 | $1.08 | -0.30% |
| Week 2 | $0.8624 | $0.9841 | $1.12 | -0.60% |
| Week 3 | $0.8347 | $0.9811 | $1.15 | -0.89% |
| Week 4 | $0.8116 | $0.9782 | $1.18 | -1.19% |
| Week 5 | $0.7916 | $0.9753 | $1.20 | -1.49% |
| Week 6 | $0.7736 | $0.9724 | $1.22 | -1.78% |
| Week 7 | $0.7573 | $0.9695 | $1.24 | -2.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MEDIROM Healthcare Technologies Inc. is a Tokyo-based company that provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty.
The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands.
The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques.
The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
MRM is currently priced at $0.9661, with a market capitalization of $7.63M. It ranks 5194 by market cap.
The 30-day technical picture shows a BEARISH sentiment with RSI14 at 40. The stock trades below the SMA50 of $1.10 and far below the SMA200 of $1.58, suggesting current downside pressure.
Near-term support sits at $0.966 and resistance at $1.20. The 30-day price range spans from $0.7704 to $1.21, highlighting limited upside momentum in the short term. The forecast table projects a mixed near-term path, with several years showing neutral momentum before a longer-term upswing appears in later years.
A major floor 21.7% below — a decisive break under it would weaken the trend.
The nearest floor, 5.7% below — buyers have tended to step in here.
The nearest ceiling, 21.2% above — a clean break opens room to run.
A major ceiling 36.4% above — clearing it would confirm fresh momentum.
Key MRM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MRM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.989 | Buy | $0.9879 | Buy |
| MA 10 | $1.01 | Sell | $1.01 | Sell |
| MA 20 | $1.07 | Sell | $1.05 | Sell |
| MA 50 | $1.10 | Sell | $1.10 | Sell |
| MA 100 | $1.16 | Sell | $1.21 | Sell |
| MA 200 | $1.57 | Sell | $1.40 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.27 | Neutral |
| Stoch RSI (14) | 61.98 | Neutral |
| CCI (20) | -79.97 | Neutral |
| Williams %R (14) | -66.27 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -6.60 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 33.73 | Neutral |
| TRIX (15) | -0.36 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 38.22 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.95 | Buy |
| ADX (14) | 17.11 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day picture shows a BEARISH sentiment with RSI14 at 40. The SMA50 is reported at $1.10 and the SMA200 at $1.58, indicating price weakness versus both moving averages. Support is noted at $0.966 and resistance at $1.20. The 30-day range runs from $0.7704 to $1.21, illustrating a narrow recent trading band with limited upside.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.91 | $0.99 | $1.23 | 0% | Neutral | |
| $0.7244 | $0.9353 | $1.29 | -6% | Neutral | |
| $0.6343 | $0.8501 | $1.23 | -14% | Neutral | |
| $0.6782 | $0.9376 | $1.40 | -5% | Neutral | |
| $0.816 | $1.16 | $1.79 | +17% | Neutral | |
| $0.798 | $1.16 | $1.84 | +18% | Neutral | |
| $0.7819 | $1.17 | $1.89 | +18% | Neutral | |
| $0.6998 | $1.07 | $1.76 | +8% | Neutral | |
| $0.6574 | $1.03 | $1.73 | +4% | Neutral | |
| $0.8026 | $1.28 | $2.19 | +29% | Bullish | |
| $0.7978 | $1.40 | $2.58 | +41% | Bullish | |
| $1.33 | $2.77 | $5.68 | +180% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.91 | $0.99 | $1.17 | +0.00% |
| August 2026 | $0.8269 | $0.984 | $1.21 | -0.61% |
| September 2026 | $0.7929 | $0.9521 | $1.19 | -3.24% |
| October 2026 | $0.7498 | $0.9074 | $1.14 | -4.70% |
| November 2026 | $0.7612 | $0.9273 | $1.18 | +2.20% |
| December 2026 | $0.7809 | $0.9572 | $1.23 | +3.23% |
Click any year to see its month-by-month MRM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MRM could reach as high as $1.23, with a base case around $0.99 and support toward $0.91 — roughly 0% from $0.99. A consolidation phase looks the most probable path here.
Expect MRM to range from $0.7244 to $1.29 through 2027. The $0.9353 average target implies a -6% move from current prices. That is -6% versus the projected 2026 average. Price action looks broadly range-bound.
The MRM price prediction for 2028 points to an average of $0.8501 (low $0.6343, high $1.23) — a potential decline of -14% on today's $0.99. A consolidation phase looks the most probable path here.
In 2029, MRM is projected to trade between $0.6782 and $1.40, averaging $0.9376 — a potential decline of -5% from today's $0.99. That is up +10% on the projected 2028 average. Price action looks broadly range-bound.
MEDIROM Healthcare Technologies Inc.'s 2030 outlook centres on $1.16, within a $0.816 to $1.79 range. That is up +24% on the projected 2029 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, MRM could reach as high as $1.84, with a base case around $1.16 and support toward $0.798 — roughly +18% from $0.99. Price action looks broadly range-bound.
Expect MRM to range from $0.7819 to $1.89 through 2032. The $1.17 average target implies a +18% move from current prices. That is up 0% on the projected 2031 average. A consolidation phase looks the most probable path here.
The MRM price prediction for 2033 points to an average of $1.07 (low $0.6998, high $1.76) — a potential gain of +8% on today's $0.99. Price action looks broadly range-bound.
In 2034, MRM is projected to trade between $0.6574 and $1.73, averaging $1.03 — a potential gain of +4% from today's $0.99. That is -4% versus the projected 2033 average. A consolidation phase looks the most probable path here.
MEDIROM Healthcare Technologies Inc.'s 2035 outlook centres on $1.28, within a $0.8026 to $2.19 range. That is up +25% on the projected 2034 average. That marks a +29% change versus current levels. Momentum favours further upside here.
By 2040, MRM could reach as high as $2.58, with a base case around $1.40 and support toward $0.7978 — roughly +41% from $0.99. Buyers look set to stay in control over this stretch.
Expect MRM to range from $1.33 to $5.68 through 2050. The $2.77 average target implies a +180% move from current prices. That is up +98% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MRM today (≈ 1,010.10101 MRM) could be worth
$2,799.12
+$1,799.12 (+180%) by 2050 · US Dollar
Based on the average projected MRM price of $2.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MRMwould be worth at today's price.
$1,000 invested in MRM on Jul 10, 2025 (≈ 740.192477 MRM) would be worth
$732.79
-$267.21 (-26.7%) today · 0.73× · US Dollar
Based on a MRM entry price of $1.35 vs. today's $0.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.07 | $925.23 | -7.5% |
| 1 month ago | $1.16 | $853.45 | -14.7% |
| 3 months ago | $1.11 | $891.89 | -10.8% |
| 6 months ago | $1.85 | $535.14 | -46.5% |
| 1 year ago | $1.35 | $732.79 | -26.7% |
| All time (5.0y) ago | $8.54 | $115.93 | -88.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MRM forecast.
Our base-case forecast reaches $2.00 around 2050.
Implied market cap at $2.00: $15.8M
The multi-year forecast shows a path toward higher prices in the long run. For 2030 the avg price is $1.12 with ROI 15.7; the 2035 forecast is $1.23 with ROI 27.2, and the 2040 forecast is $1.37 with ROI 41.5. The 2050 forecast envisions an avg of $2.70 with ROI 179.5.
The forecast also includes years labeled NEUTRAL in the near term, such as 2026 with avg $0.9661 and 2027 with avg $0.9121, continuing through 2034 with various neutral readings. Notable bullish years appear in 2035 (avg $1.23) and beyond, with 2040 (avg $1.37) and 2050 (avg $2.70) showing stronger upside.
There are some years with negative ROI in the nearer term, specifically 2027 (-5.6), 2028 (-13.7), and 2029 (-6.5). These figures are estimates, not guarantees, and should be considered within the context of fluctuating markets and the asset’s inherent risk.
Tap a question to reveal the answer.
Avg $1.12, min $0.7912, max $1.71; ROI 15.7; sentiment NEUTRAL.
The forecast shows positive ROIs in the longer term (e.g., 2030 15.7, 2031 17.4, 2032 17.6, 2035 27.2, 2040 41.5, 2050 179.5) but also negative ROIs in 2027 (-5.6), 2028 (-13.7), and 2029 (-6.5). These are estimates, not guarantees.
Yes. The forecast max values reach $2.09 in 2035, $2.50 in 2040, and $5.47 in 2050.
Current price is $0.9661 and market cap is $7.63M.
Sentiment BEARISH; RSI14 is 40; SMA50 $1.10; SMA200 $1.58; support $0.966; resistance $1.20; 30-day range from $0.7704 to $1.21.
MEDIROM Healthcare Technologies Inc. Community Discussion
0Share your MEDIROM Healthcare Technologies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.